Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder. - Wikidata - awgldk - TriplyDB

Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.

Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.

http://www.wikidata.org/entity/Q34032634

about

Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamine Associations of sleep disturbance with ADHD: implications for treatment Effects of the dopamine/norepinephrine releaser phenmetrazine on cocaine self-administration and cocaine-primed reinstatement in rats The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Lisdexamfetamine: A Review in ADHD in Adults.Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells.Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis.

P2860

Q26752974-C2789F86-4336-4280-8401-1BCC9DAE0040 Q27027062-4FDCDE17-4888-465F-9F37-D3F8C21C2113 Q35738069-A9DD3930-D93B-4868-83EB-ABF34589120E Q38221823-A7775E08-B713-4E53-B6FA-649B7DC1ABEB Q38799006-28762535-A7B0-4679-A717-10EBA2A16BD4 Q41127210-174DF188-9164-4E2D-9670-F16C3144327D Q41312831-3F27EECC-1B1F-420E-8309-B3D49DAFDCAB Q41833735-1223F66A-3EEA-4560-BD62-D521EDC790F9 Q45012725-B000F068-C618-4814-8AFC-0496633E4826

P2860

Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.

http://www.wikidata.org/entity/Q34032634

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@ast

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@en

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@nl

type

label

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@ast

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@en

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@nl

prefLabel

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@ast

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@en

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@nl

P1433

Q34032634-2B41F80E-D1D5-4D45-B678-F07F465FBC03

P1476

Q34032634-CA1939DA-BAB5-48EC-BDD5-9CE2BC4BDB5B

P2093

Q34032634-0F9A17E3-DCC9-4796-8A5C-6A915427A64B

Q34032634-561F7F45-1D31-455C-A961-4B928ECE7638

Q34032634-6C2DA1C6-ECA0-4F1A-9919-2228228B6355

Q34032634-DA3241CC-5CE8-4B71-BC66-767E9A100724

Q34032634-DC65F27B-A3AE-481D-A793-157B61ADC044

P2860

Q34032634-04617502-7767-4193-A391-37EE584791F3

Q34032634-1605901C-5108-48A8-B2E7-237DB96C5044

Q34032634-16966641-40FC-4725-A902-73CCD19739B0

Q34032634-18806B05-3D51-4F3A-9550-A92A582F44F4

Q34032634-2DF7153B-1454-42C5-BE2A-2920C4C5AB1F

Q34032634-38E024A3-CA3C-4088-B466-27CC8CF0999C

Q34032634-3D4ADE59-2215-45F3-BB17-6ADE937C97A2

Q34032634-3E65CDF0-8EB1-4F48-84A5-759AD825A1C3

Q34032634-3EEFD34E-F8F8-4120-B448-571601AE57F9

Q34032634-4034AE6B-66A3-43A2-B7E5-AFAF8B5BE12C

P2888

Q34032634-7FA5B295-8EC0-4740-A78C-0D8A6E515BCC

P304

Q34032634-DF70261A-552B-4D31-BC5E-A019FA4E85D2

P31

Q34032634-FAEE9320-2435-4CA5-9832-DB6FBDF851D9

P356

Q34032634-0B3F0171-981E-4BF3-A890-3DC1E37B5D81

P433

Q34032634-CBBB9B0A-A7C1-4E5B-B1EB-B7CDC1F5A2B5

P478

Q34032634-903B5CF7-DB2C-4754-AB86-F8016737811C

P577

Q34032634-F2686B08-06A6-4361-8006-D770782AB473

P5875

Q34032634-4C339881-DAA7-4557-8D03-37E5F654E674

P6179

Q34032634-839A08CB-5AF2-4685-B7CD-07980A0CED2C

P698

Q34032634-235B4E47-7C68-47D3-A3BB-99CA95DF6A09

P921

Q34032634-4A1A3571-B167-4564-9431-410CC9C48C5E

Q34032634-C4F4A60F-4212-459D-ADAC-6F28B681BD3A

P356

11634340-000000000-00000

P1433

P1476

Lisdexamfetamine dimesylate: a ...... eficit hyperactivity disorder.

@en

P2093

Christopher Steer

http://www.w3.org/2001/XMLSchema#string

César A Soutullo

http://www.w3.org/2001/XMLSchema#string

Jan Froelich

http://www.w3.org/2001/XMLSchema#string

Mats Johnson

http://www.w3.org/2001/XMLSchema#string

Monica Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

ADHD in Children Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity Disorder

Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

P2888

11634340-000000000-00000

P304

691-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11634340-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228323743

http://www.w3.org/2001/XMLSchema#string

P6179

1046855839

http://www.w3.org/2001/XMLSchema#string

P698

22762726

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder